# Minocycline add-on to Antipsychotics for the Treatment of Negative and Cognitive Symptoms in Schizophrenia

> **NCT02907437** · PHASE3 · UNKNOWN · sponsor: **Beer Yaakov - Ness Ziona Mental Health Center** · enrollment: 40 (estimated)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Minocycline
- **DRUG:** Placebo
- **OTHER:** Probiotics

## Key facts

- **NCT ID:** NCT02907437
- **Lead sponsor:** Beer Yaakov - Ness Ziona Mental Health Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2017-02
- **Final completion:** 2018-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2016-09-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02907437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02907437, "Minocycline add-on to Antipsychotics for the Treatment of Negative and Cognitive Symptoms in Schizophrenia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02907437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*